31 P magnetic resonance spectroscopy ( 31 P MRS) studies have shown abnormal membrane phospholipid metabolism in the prefrontal cortex (PF) in the early course of schizophrenia. It is unclear, however, whether these alterations also represent premorbid risk indicators in schizophrenia. In this paper, we report in vivo 31 P MRS data on children and adolescents at high risk (HR) for schizophrenia. In vivo 31 P MRS studies of the PF were conducted on 16 nonpsychotic HR offspring of parents with schizophrenia or schizoaffective disorder, and 37 age-matched healthy comparison (HC) subjects. While 11 of the HR subjects had evidence of Axis I psychopathology (HR-P), five HR subjects had none (HR-NP). We quantified the freely mobile phosphomonoester (PME) and phosphodiester (PDE) levels reflecting membrane phospholipid precursors and breakdown products, respectively, and the relatively broad signal underlying PDE and PME peaks, comprised of less mobile molecules with PDE and PME moieties (eg, synaptic vesicles and phosphorylated proteins). Compared to HC subjects, HR subjects had reductions in freely mobile PME; the differences were accounted for mainly by the HR-P subjects. Additionally, HR-P subjects showed increases in the broad signal underlying the PME and PDE peaks in the PF. To conclude, these data demonstrate new evidence for decreased synthesis of membrane phospholipids and possibly altered content or the molecular environment of synaptic vesicles and/or phosphoproteins in the PF of young offspring at risk for schizophrenia. Follow-up studies are needed to examine the predictive value of these measures for future emergence of schizophrenia in at-risk individuals.
Several lines of evidence suggest that the pathogenesis of schizophrenia may be mediated by abnormal neurodevelopment. These include the typical onset in adolescence; pronounced premorbid neurodevelopmental abnormalities such as attentional and neuromotor impairments; minor physical anomalies; presence of structural abnormalities at the onset of illness that may even predate the illness; and neuropathological observations of altered cortical cytoarchitecture. [1] [2] [3] [4] The timing of the neurodevelopmental abnormality, however, remains controversial. 'Early' neurodevelopmental models posit a dysfunctional neural network as a result of pre-or perinatal developmental deviations; 2,3 on the other hand, 'late' neurodevelopmental models propose an aberration in brain maturational processes such as synaptic pruning in the prefrontal (PF) and related brain structures during late childhood and adolescence. [5] [6] [7] [8] In vivo phosphorus magnetic resonance spectroscopy ( 31 P MRS) is a noninvasive technique that can assess the membrane phospholipid and high-energy phosphate metabolism in localized brain regions. The measurable in vivo 31 P metabolites include freely mobile, rapidly tumbling phosphomonoesters leading to narrow spectral resonances (free-PME), freely mobile phosphodiesters (free-PDE), phosphocreatine (PCr), inorganic orthophosphate (Pi) and adenosine triphosphate (ATP). 7, 9 The free-PMEs are primarily precursors, and free-PDEs are primarily breakdown products of membrane phospholipids (ie, phosphorylcholine (PC) and phosphorylethanolamine (PE), and glycerolphosphocholine (GPC) and glycerolphosphoethanolamine (GPE), respectively). Higher free-PME levels are observed at the time and site of neuritic sprouting, and higher free-PDE levels are observed at the site and time of neuronal membrane breakdown. 10 Since cell membranes are continually generated and broken down, expressing the free-PME and free-PDE levels as a ratio provides a measure of turnover equilibrium of membrane phospholipids. In addition to the narrow spectral resonances, in vivo brain 31 P spectra contain broad underlying signals primarily over the PME and PDE spectral regions. Under typical in vivo acquisition conditions, this broad signal comprises of molecules with PDE (and PME) moieties that are less mobile than the free-PDE and free-PME molecules and more mobile than the larger membrane phospholipid-containing bilayer structures. These molecules with 'intermediate' mobility (termed broad-PDE) may include synaptic/ transport vesicles and micelles, and to a lesser degree phosphorylated proteins, [11] [12] [13] [14] [15] [16] and can also be reliably quantified.
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A major advantage of in vivo 31 P spectroscopy is its ability to noninvasively investigate the development of the human brain. The free-PME and free-PDE levels, respectively, are sensitive to the anabolic and catabolic activities of membrane phospholipids that occur during neurodevelopment. Early in postnatal brain development, levels of membrane phospholipid precursors are high and breakdown products are low; this is followed by dramatic decreases in precursor levels and increases in breakdown products, which then plateau, as the brain reaches late adolescence. [17] [18] [19] [20] [21] [22] In vivo 31 P MRS studies have shown lower PME levels and higher PDE levels in the PF 7, [23] [24] [25] and temporal lobe 26 of first-episode, neuroleptic naïve schizophrenia subjects, compared to matched controls. Reduced PME correlate with Wisconsin Cart Sorting test performance 27 and negative symptoms 28 in schizophrenia, implicating the PF in the pathogenesis of this disorder (for a review, see Keshavan et al
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. The PME reduction and PDE increases in schizophrenia appear to be enhanced relative to normative changes during childhood and adolescence; it has therefore been suggested that these 31 P MRS alterations may reflect an increase in membrane phospholipid turnover, perhaps because of an accelerated synaptic pruning process during late childhood/early adolescence. 5, 7, 8, 30 To further investigate possible trait-related markers of the underlying neurodevelopmental pathogenesis of schizophrenia, one can conduct 31 P spectroscopy studies in individuals at increased genetic risk, such as child and adolescent offspring of parents with this illness. In view of previous in vivo 31 P spectroscopy studies showing alterations of membrane phospholipid metabolites in the PF of schizophrenia subjects 7, [23] [24] [25] and relatives at risk for this disorder, 31 we hypothesized that high-risk (HR) child and adolescent offspring of parents with schizophrenia would show alterations in membrane phospholipid metabolites, in the PF region, compared to matched healthy comparison (HC) subjects. Considering our specific predictions on the PF regions suggested by our prior work, we focus this report on the PF; data on other brain regions will be reported elsewhere. Additionally, several longterm follow-up studies of HR offspring of schizophrenia subjects have indicated that nonpsychotic psychopathological manifestations, such as attentional impairments, frequently precede the emergence of this illness. 32, 33 For this reason, we also hypothesized that HR offspring who have already shown early signs of psychopathology would show a relatively greater degree of 31 P metabolite abnormalities in the PF region than HR offspring with no such features.
Methods

Subjects
Subjects included 16 HR offspring (eight males and eight females; mean age 15.472.2 years; age range 11.0-17.9 years; full-scale IQ 101716) of a parent with schizophrenia (n ¼ 6) or with a schizoaffective disorder (n ¼ 10). The diagnosis of the affected parent was derived using the Structured Clinical Interview for DSM-IV schizophrenia (SCID). 34 The HR subjects were recruited by contacting the in-patients and outpatients at the Western Psychiatric Institute and Clinic (WPIC). We also recruited 37 age-matched HC subjects without psychiatric history in self or firstdegree relatives (29 males and eight females; mean age 14.272.7 years; age range 10.0-19.9 years; fullscale IQ 106713). The HC subjects were recruited from the same communities as those from which the HR subjects were recruited. A telephone and personal interview, as well as a screening questionnaire, were used to ascertain and rule out subjects with a history of psychotic illness in first-degree relatives. The Institutional Review Board of the University of Pittsburgh Medical Center approved the study. All subjects provided informed consent after full description of the study. For subjects aged less than 18 years, the parent/guardian also provided the informed consent. Subjects younger than 15 years were clinically evaluated using the Schedule for Affective Disorders and Schizophrenia F Child Version (K-SADS) 35 and those aged 15 years or above were assessed using the SCID. 34 Five subjects (two males and three females) were free of psychiatric illness (HR-NP), and 11 subjects (six males and five females) had one or more lifetime psychiatric disorder diagnoses (HR-P): attention-deficit hyperactivity disorder, n ¼ 7; conduct disorder, n ¼ 5; oppositional defiant disorder, n ¼ 2; depressive disorder, n ¼ 4; bipolar disorder, n ¼ 2; substance use disorder in remission, n ¼ 2; post-traumatic stress disorder, n ¼ 1; eating disorder, n ¼ 1 and simple phobia, n ¼ 1 (numbers add up to 411 because of comorbidity). The mean illness duration for these disorders was 124.63 þ 83.21 months. Lifetime history of medication use was as follows: oral contraceptives, n ¼ 2; methylphenidate, n ¼ 1; dextroamphetamine, n ¼ 1; thioridazine, n ¼ 1; albuterol, n ¼ 1 and paroxetine, n ¼ 1. Subjects with neurologic or medical illness or IQ o 75 were excluded. In view of our goal of identifying prepsychotic neurobiological precursors, we excluded HR offspring who had any lifetime evidence of psychotic disorders. HC subjects who had a lifetime history of Axis I psychiatric disorder, history of Axis I psychiatric disorder in any firstdegree family members, neurologic disorders, chronic
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MRI procedure
All MR examinations were conducted on a 1.5 Tesla whole body MR system, using a custom-built dualtuned, 1 H and 31 P transmit/receive quadrature head coil. 36 A 10 s, single axial slice acquisition sequence (2D fast gradient echo) was first obtained to ensure that the midline of the brain coincides with the anterior-posterior direction and to verify subject's cooperation and image quality. A set of sagittal scout images (2D fast spin echo), and a set of proton density and T 2 -weighted axial images covering the whole brain (2D fast spin echo, TR ¼ 2500 ms, TE ¼ 17 and 102 ms, FOV ¼ 240 mm, approximately 24 slices, slice thickness ¼ 5 mm, slice gap ¼ 0 mm, NEX ¼ 1, matrix 25 Â 192) were collected. The latter set of images were examined by a neuroradiologist to ensure that there were no abnormal signal intensities or structures.
P MRS acquisition
To acquire the 2D multi-voxel in vivo 31 P MRS data, a self-refocused, slice-selective spin-echo pulse sequence 37 was used. The localized 30 mm thick axial slice was positioned such that the inferior edge of the slice coincides with the anterior commissure-posterior commissure line, as illustrated Figure 1 . The spinecho sequence had an effective flip angle of 601, an effective echo time of 2.5 ms and an excitation bandwidth of 1200 Hz, and the phase encoding gradients were executed prior to the collection of the echo for spatially encoding the 2D axial slice. 31 P MRS data, the 8 Â 8 grid was shifted relative to the anatomical images to ensure that the right and left 31 P voxels were optimally positioned to sample the PF (Figure 1) . A mild spatial apodization (ie, Fermi window with 90% diameter and 5% transition) was then applied followed by the 2D inverse FT. Based on empirical calculations, the resulting effective voxel size was approximately 69 cm 3 . The signal in the chemical shift dimension was left in the time domain for quantification. All subsequent steps to quantify 31 P MRS data were 100% automated on a Unix workstation using in-house software, SAGE procedures (GE Medical Systems), IDL (Research Systems, Inc.) and, Matlab (The Math Works, Inc.) and, therefore, the results are independent of operator input.
In quantifying the PME, Pi, PDE, PCr and ATP (two doublets and a triplet) resonances, each free induction decay (FID) signal was modeled with 11 exponentially damped sinusoids in the time domain using the nonlinear least-squares Marquardt-Levenberg algorithm. 38 The modeled parameters for each resonance include the amplitude estimated at time zero, which is proportional to the spectral area of the peak, exponential decay constant, chemical shift, zeroth order phase and the preacquisition delay time (DT). To segregate and quantify the freely and less mobile molecules over the PME and PDE spectral region (ie, the free-PME, free-PDE and broad-PDE levels), we used a time-domain fitting method;
11 this allowed us to omit data points at the beginning of the FID without requiring additional corrections to the baseline, as it would if quantified in the frequency domain. Each FID was processed using a short DT (1.0 ms) and a long DT (2.75 ms) (ie, the first 4 and 11 points of the FID, respectively, were excluded in the fit). By modeling the FID with a long DT, the signal amplitude of the broad-PDE is negligible and its influence on the quantified PME and PDE resonances also is negligible. Therefore, the quantified PME and PDE resonances reflect the free-PME and free-PDE metabolites, respectively. Taking the total amplitude difference between the two DT fits resulted in the broad-PDE level. 11 In all cases, the metabolite levels were expressed as a percentage relative to the total amplitude of the short DT results. Expressing metabolite levels as a mole percent requires no correction for the amount of cerebral spinal fluid (CSF) within the sampled voxel. A typical example of modeling the right and left PF voxels of an HC subject is shown in Figure 1 . Data analysis A linear regression model based on the generalized estimating equations (GEE) 39 and implemented in the GENMOD procedure of SAS (Release 8.0, SAS Institute, Inc., Cary, NC, USA) was used. The metabolite levels (free-PME, free-PDE, PCr, Pi, b-ATP and broad-PDE) and ratios (free-PME/free-PDE and PCr/Pi) from the right and left PF voxels were treated as 'repeated measures' in this analysis, since these measurements are correlated within subjects. In the interaction models, the post hoc analysis included the differences of least-squares means of the interaction terms. P-values of 0.05 or less (two-tailed) were considered significant. The study's primary hypothesis was to test whether there are significant differences in metabolite levels in the PF between HR offspring and HC subjects, as well as between HR offspring with and without Axis I psychopathology (HR-P and HR-NP, respectively) and HC subjects. The first model included the main effects, subject-group (HR or HC), age, gender (male or female) and hemisphere (right or left), and the second model was the same as above except that the subject-group included HR-P, HR-NP and HC subjects. To address hemisphere effect, the hemisphere-bygroup interaction term was added to the latter model.
Results
HR vs HC
A two-tailed t-test showed no significant difference in age (P ¼ 0.12) or full-scale IQ (P ¼ 0.22) between HR offspring and HC subjects. In the PF, HR offspring showed decreased free-PME (mean7SD, 11.172.2 vs 12.272.2; P ¼ 0.0056) levels and decreased free-PME/ free-PDE ratios (0.33570.062 vs 0.36670.063; P ¼ 0.040) compared to the HC subjects ( Table 1) . The free-PME levels are plotted in Figure 2 .
Dichotomizing the HR subjects By dichotomizing the HR offspring, the decreased free-PME (10.571.3 vs 12.272.2; Po0.0001) and free-PME/free-PDE (0.31970.045 vs 0.36670.063; P ¼ 0.0003) were only significant in the HR-P subjects and not in HR-NP subjects, both relative to HC subjects (Table 2 and Figure 2) . Additionally, the broad-PDE levels were significantly higher in HR-P compared to HC subjects (15.776.7 vs 12.777.2; P ¼ 0.045; Table 2 ). Within the HR-P group, there were no significant differences between subjects with and without a lifetime history of medication use.
Hemisphere effects with the dichotomized HR subject There were no significant hemisphere-by-group interactions in the 31 P metabolite levels or ratios. However, the differences of least-squares mean results show a bilateral reduction in the free-PME levels of HR-P subjects compared to HC subjects (right: P ¼ 0.0009; left: P ¼ 0.0002; Figure 2 ). The decreased free-PME/ free-PDE ratios in HR-NP subjects are primarily lateralized to the left side (Po0.0001).
Discussion
As predicted in the study's primary hypothesis, free-PME levels were significantly lower in the PF of child and adolescent HR offspring compared to HC subjects. Specifically, this reduction in free-PME levels was bilateral and present only in HR-P offspring subjects and not in HR-NP offspring subjects, compared to HC subjects. Similar to the free-PME finding, the equilibrium of membrane phospholipid turnover, as measured by the free-PME/free-PDE ratio, was lower bilaterally only in HR-P offspring subjects compared to controls.
Decreased PME (without the differentiation between the freely and less mobile metabolites) has been reported in the PF of first-episode, neurolepticnaive schizophrenia subjects, 7, 25 as well as in the PF of chronic schizophrenia subjects. 25, 40, 41 Studies that have attempted to differentiate the PME and PDE components also have shown reduced free-PME in the PF of chronic schizophrenia 41 and first-episode schizophrenia subjects. 42 These studies, together with the results from the HR-P subjects in this study, suggest a reduction of membrane synthesis as a traitrelated manifestation of the illness. Reduced membrane synthesis may perhaps relate to reduced cortical neuropil as evidenced by reduced gray matter volume, [43] [44] [45] reduced somal size of some neuronal populations, 46 ,47 decreased number of axon terminals in the distal dendrites and dendritic spines 48 and decreased expression of genes involved in the regulation of presynaptic function in the PF of subjects with P metabolite level (mol%)71 SD. b Parameter estimate or estimate effect size (P-value) from the analysis of generalized estimating equations. The results of the gender, age and hemisphere terms are not shown. *Significant differences.
In vivo 31 P MRS study on offspring of schizophrenia parents MS Keshavan et al schizophrenia. 49 It has been suggested that such a reduction in synaptic neuropil is the result of an exaggeration of the normal synaptic pruning, 5, 7, 8 which occurs during late childhood and early adolescence. Considering the age range of these HR-P subjects suggests the deficit in the PF, possibly reflecting underdeveloped neuronal processes and synapses, may be present even earlier, at least in subjects with an increased genetic risk for schizophrenia.
A major strength of our study was the ability to segregate and quantify the freely mobile membrane Figure 2 The right and left PF PME(s-tc) levels plotted as a function of age for the HC (J) subjects, (a) and (c), and for the HR-P (*) and HR-NP ( Â ) subjects, (b) and (d). The regression lines of the HC subjects, which have been ''smoothed'' using the Lowess algorithm, are displayed. Refer to text for significant differences. phospholipid metabolites and the less mobile molecules with PME and PDE moieties. 11 The less mobile molecules (broad-PDE) were increased in the HR-P subjects compared to comparison subjects. This observation is consistent with the increased broad-PDE observed in first-episode never-medicated subjects with schizophrenia 42 and in chronic medicated subjects. 41 The increased broad-PDE in the PF of HR-P subjects may either reflect increased phosphorylated proteins and/or increased synaptic/transport vesicles. 12 Additionally, it may be that the observed increases in synaptic vesicles and/or proteins reflect a compensatory increase in synaptic activity or sprouting in individuals at risk for the illness. 50 Post-mortem studies, however, show both decreased 51 and increased presynaptic proteins 52, 53 in schizophrenia. An alteration of the membrane phospholipid bilayer environment in schizophrenia such as membrane fluidity 54, 55 also may impair the processes of exocytosis of the synaptic vesicles and neurotransmitter release, leading to a buildup of phospholipidcontaining synaptic/transport vesicles that may be MRS 'visible'. Alternatively, the increased broad-PDE signal may be because of a decrease in the correlation time of the broad-PDE components as a result of increased motion and/or decreased size of phospholipid-containing synaptic/transport vesicles or phosphorylated proteins of the membrane phospholipid bilayer structure.
In our study, children and adolescents at increased genetic risk for schizophrenia with Axis I psychopathology, especially developmental abnormalities such as attention-deficit disorders, showed more prominent MRS abnormalities levels in the PF compared to HP-NP and HC subjects. While the lifetime risk of schizophrenia and related psychotic disorders among HR offspring is relatively small (about 18%), 56 a larger population (up to 40%) develop broadly defined schizophrenia spectrum disorders including schizotypy and schizotaxia. [56] [57] [58] [59] Previous retrospective or follow-back studies in schizophrenia 60, 61 and prospective studies of offspring at high risk for schizophrenia 62, 63 have described an association between nonpsychotic childhood behavioral disturbance and the subsequent development of psychotic disorders including schizophrenia. Psychopathological features such as attentional impairments occur frequently in the premorbid phase of schizophrenia, and are among the most robust markers predicting risk for schizophrenia among the offspring of schizophrenia patients 64 (for a review, see also Cornblatt et al 65 ). Alterations in the structural and biochemical integrity of the prefrontal cortex have been described in children and adolescents with ADHD, conduct disorder and bipolar disorders, 66, 67 although the results are inconsistent and few 31 P MRS studies have been published in these disorders. Nevertheless, the observed abnormalities could conceivably have been a result of such comorbid disorders. HR subjects who have already begun to manifest one or other comorbid Axis I psychiatric disorder might be at a higher risk for the eventual unfolding of psychotic disorders; prospective follow-up studies are needed to examine the question of whether neurobiological alterations in such 'super-high risk' individuals can help prediction of clinical outcome. Our observations strongly support the possibility that neurochemical alterations in PF in schizophrenia are related to underlying neurodevelopmental vulnerability to the eventual emergence of the illness.
Our study confirms and extends the observations by the only other 31 P MRS study in young relatives at risk for schizophrenia, which also reported decreased PME/PDE ratios and increased PDE values in the PF. 31 To our knowledge, ours is the first study in HR subjects examining the broad components underlying the 31 P MRS signals that reflect synaptic vesicles and phosphorylated proteins. Nevertheless, the relatively small sample size is a limitation of our study, and the findings should therefore be considered preliminary. The possibility of anatomical alterations in PF could potentially confound the interpretation of the metabolite data in the PF. However, in a subset of these patients, we have computed the volumes of the prefrontal structures, and have not found any differences between HR and HC subjects. 68 Additionally, because of the limitation in the sensitivity of the 31 P nuclei, the localized 31 P voxel size is much larger than the voxel size typically used in 1 H spectroscopy. Given that the spatial resolution is poorer, this study cannot deduce any information of possible alterations of substructures within the prefrontal region. Future studies can include conducting 31 P spectroscopy at higher field strength to resolve smaller anatomical structures.
Studies of observed 31 P MRS abnormalities in combination with clinical and neurocognitive indicators of vulnerability may allow a better delineation of premorbid pathophysiology. The recent availability of high-field scanners (B3 Tesla or higher) and the use of proton decoupling can further resolve the 31 P MRS metabolites. 69 Studies with simultaneous 31 P and 1 H MRS protocols are also valuable in obtaining convergent neurochemical information across all brain regions. Follow-up studies of these children throughout adolescence and early adulthood are needed to clarify whether the observed brain abnormalities can eventually predict the development of schizophrenia and related psychotic disorders.
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